Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,710 | 26 | 62.2% |
| Food and Beverage | $24,553 | 904 | 34.2% |
| Travel and Lodging | $1,894 | 15 | 2.6% |
| Education | $693.29 | 16 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $30,844 | 126 | $0 (2024) |
| Allergan, Inc. | $20,850 | 97 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $2,098 | 93 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $2,093 | 71 | $0 (2024) |
| LivaNova USA, Inc. | $1,208 | 11 | $0 (2022) |
| Biogen, Inc. | $1,196 | 84 | $0 (2022) |
| Amgen Inc. | $1,036 | 38 | $0 (2024) |
| EMD Serono, Inc. | $963.93 | 38 | $0 (2023) |
| Medtronic Vascular, Inc. | $787.34 | 8 | $0 (2017) |
| Genentech USA, Inc. | $784.12 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,085 | 85 | ABBVIE INC. ($5,822) |
| 2023 | $5,848 | 73 | ABBVIE INC. ($4,480) |
| 2022 | $11,133 | 126 | ABBVIE INC. ($8,988) |
| 2021 | $17,469 | 171 | AbbVie Inc. ($11,376) |
| 2020 | $17,474 | 132 | Allergan, Inc. ($15,748) |
| 2019 | $3,491 | 127 | Novartis Pharmaceuticals Corporation ($619.67) |
| 2018 | $4,077 | 116 | LivaNova USA, Inc. ($1,005) |
| 2017 | $4,273 | 131 | Medtronic Vascular, Inc. ($787.34) |
All Payment Transactions
961 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $144.41 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/11/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.58 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $3.91 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.00 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.96 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $127.31 | General |
| Category: Neurology | ||||||
| 10/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: PAIN | ||||||
| 10/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $123.44 | General |
| Category: Central Nervous System | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Neurology | ||||||
| 09/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $36.70 | General |
| Category: Urology | ||||||
| 09/26/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $30.44 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Neurology | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $124.38 | General |
| Category: Neuroscience | ||||||
| 09/19/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Neuroscience | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Neurology | ||||||
| 09/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 709 | 7,334 | $220,983 | $108,437 |
| 2022 | 13 | 896 | 13,782 | $381,735 | $225,617 |
| 2021 | 11 | 818 | 12,624 | $315,766 | $198,876 |
| 2020 | 14 | 886 | 13,573 | $338,549 | $199,971 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 264 | 390 | $72,555 | $39,209 | 54.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 15 | 6,449 | $77,464 | $31,862 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 149 | $19,421 | $11,145 | 57.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $16,034 | $7,634 | 47.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 67 | 91 | $11,794 | $5,201 | 44.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 34 | $8,160 | $4,938 | 60.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $7,640 | $3,869 | 50.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 44 | 56 | $4,088 | $1,674 | 40.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 19 | 19 | $1,516 | $1,427 | 94.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 32 | $1,856 | $1,069 | 57.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 13 | 13 | $455.00 | $408.86 | 89.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 347 | 495 | $110,657 | $76,675 | 69.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 26 | 12,600 | $94,200 | $61,614 | 65.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 154 | 219 | $36,032 | $23,871 | 66.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 101 | 101 | $42,940 | $19,066 | 44.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 108 | 132 | $16,526 | $9,945 | 60.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $13,903 | $6,961 | 50.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 15 | 15 | $8,250 | $6,386 | 77.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 16 | 41 | $19,040 | $5,307 | 27.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 13 | 13 | $6,500 | $4,682 | 72.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 19 | 19 | $17,613 | $3,735 | 21.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 48 | $5,424 | $2,894 | 53.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 17 | 25 | $5,875 | $2,320 | 39.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 25 | $4,775 | $2,162 | 45.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 19 | 11,600 | $81,200 | $59,707 | 73.5% |
About Dr. Wei Mi, M.D
Dr. Wei Mi, M.D is a Neurology healthcare provider based in Mission Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871601401.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wei Mi, M.D has received a total of $71,850 in payments from pharmaceutical and medical device companies, with $8,085 received in 2024. These payments were reported across 961 transactions from 78 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($44,710).
As a Medicare-enrolled provider, Mi has provided services to 3,309 Medicare beneficiaries, totaling 47,313 services with total Medicare billing of $732,901. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology
- Location Mission Hills, CA
- Active Since 08/25/2006
- Last Updated 01/01/2026
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1871601401
Products in Payments
- UBRELVY (Drug) $42,536
- QULIPTA (Drug) $6,704
- VNS Therapy (Device) $1,433
- KESIMPTA (Drug) $912.14
- Aimovig (Biological) $849.23
- NURTEC ODT (Drug) $715.92
- BOTOX (Biological) $585.53
- AUSTEDO (Drug) $579.15
- OCREVUS (Biological) $541.03
- GILENYA (Drug) $532.67
- NUPLAZID (Drug) $487.56
- BOTOX - NEUROLOGY (Drug) $463.07
- TECFIDERA (Drug) $416.99
- Austedo XR (Drug) $404.75
- ZEPOSIA (Drug) $400.89
- Leqembi (Drug) $398.47
- Gamunex-C (Biological) $393.61
- INGREZZA (Drug) $364.58
- AJOVY (Biological) $361.16
- BOTOX-NEUROLOGY (Drug) $344.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Mission Hills
Dr. Kanwal Nayyar, Md, MD
Neurology — Payments: $134,698
Alvin Nguyen
Neurology — Payments: $46,417
Ankur Nayyar, M.d, M.D
Neurology — Payments: $8,393
Dr. Yasuhiro Maeda, M.d, M.D
Neurology — Payments: $3,559
Dr. Craig German, Md, MD
Neurology — Payments: $1,339
Doris Cardenas, Md, MD
Neurology — Payments: $1,218